Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Lidocaine and Ketorolac for Pain Management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Emergency Medicine Patient~* clinical diagnosis of acute renal colic~* pain score of \>=5 out of 10 on the numeric rating scale~* - age 18 - 64 years of age~Exclusion Criteria:~* documented or suspected pregnancy, breastfeeding~* contraindication to nonsteroidal anti-inflammatory drugs or lidocaine~* known renal dysfunction~* received analgesics within 4 hours before presentation~* history of bleeding diathesis~* history of peptic ulcer disease~* current use of warfarin~* HR\<50 or \>150~* history of cardiac arrhythmias~* peritonitis or presence of any peritoneal sign~* altered mental status~* weight \> 100kg

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine and normal saline push (Type: ACTIVE_COMPARATOR): 1.5mg/kg IV Lidocaine Drip (given over 10 minutes) and normal saline push
- Ketorolac and normal saline drip (Type: ACTIVE_COMPARATOR): IV Ketorolac Tromethamine 30mg push and 10 minute normal saline drip
- Lidocaine and Ketorolac (Type: ACTIVE_COMPARATOR): IV Lidocaine Drip and IV Ketorolac Push

Based on this trial design, predict the completion outcome and termination type (if applicable).